World's Best Scientists 2026 revealed!
Joseph B. Muhlestein

Joseph B. Muhlestein

D-Index & Metrics

Medicine

D-Index
84
Citations
28444
World Ranking
15007
National Ranking
7586

Overview

Joseph B. Muhlestein is affiliated with the University of Utah in the United States. Their research primarily spans the field of Medicine, with a strong focus on Cardiology and Cardiovascular Medicine, where they have contributed to 54 publications. Other notable subfields include Surgery, Physiology, Radiology, Nuclear Medicine and Imaging, and Endocrinology, Diabetes and Metabolism.

The research topics covered by Muhlestein reflect a concentrated interest in cardiovascular health and metabolic processes. Key topics include:

  • Dietary Effects on Health
  • Cardiac Imaging and Diagnostics
  • Lipoproteins and Cardiovascular Health
  • Diet and metabolism studies
  • Heart Failure Treatment and Management
  • Blood Pressure and Hypertension Studies
  • Atrial Fibrillation Management and Outcomes

Muhlestein has coauthored numerous papers with several frequent collaborators. Notable coauthors include Kirk U. Knowlton, Jeffrey L. Anderson, Heidi T. May, Viet T. Le, and Tami L. Bair, each coauthoring dozens of papers with Muhlestein.

They have published extensively in several high-profile academic journals. Frequent publication venues are:

  • Circulation
  • Journal of the American College of Cardiology
  • American Heart Journal
  • Journal of Clinical Medicine
  • Frontiers in Cardiovascular Medicine

Recent papers authored or coauthored by Joseph B. Muhlestein include:

  • Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial (2020, European Heart Journal)
  • Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results (2020, Cardiovascular Research)
  • Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse (2022, European Heart Journal)
  • International consensus on fasting terminology (2024, Cell Metabolism)
  • Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled Trial (2021, American Heart Journal)

Best Publications

  • Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

    Heribert Schunkert;Inke R. König;Sekar Kathiresan;Muredach P. Reilly

  • Which White Blood Cell Subtypes Predict Increased Cardiovascular Risk

    Benjamin D. Horne;Jeffrey L. Anderson;Jeffrey L. Anderson;Jerry M. John;Jerry M. John;Aaron Weaver;Aaron Weaver

  • Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation

    Jeffrey L. Anderson;Benjamin D. Horne;Scott M. Stevens;Amanda S. Grove

  • Relation of Vitamin D Deficiency to Cardiovascular Risk Factors, Disease Status, and Incident Events in a General Healthcare Population

    Jeffrey L. Anderson;Jeffrey L. Anderson;Heidi T. May;Benjamin D. Horne;Benjamin D. Horne;Tami L. Bair

  • Ischemic Heart Disease Events Triggered by Short-Term Exposure to Fine Particulate Air Pollution

    C. Arden Pope;Joseph B. Muhlestein;Heidi T. May;Dale G. Renlund

  • Infection With Chlamydia pneumoniae Accelerates the Development of Atherosclerosis and Treatment With Azithromycin Prevents It in a Rabbit Model

    Joseph B. Muhlestein;Jeffrey L. Anderson;Elizabeth H. Hammond;Liping Zhao

  • Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease

    Joseph B. Muhlestein;Elizabeth H. Hammond;John F. Carlquist;Ellen Radicke

  • Azithromycin for the Secondary Prevention of Coronary Events

    J. Thomas Grayston;Richard A. Kronmal;Lisa A. Jackson;Alfred F. Parisi

  • An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense : Results of a randomized study (ROMIO)

    Miguel A. Gomez;Jeffrey L. Anderson;Labros A. Karagounis;Joseph B. Muhlestein

  • Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction.

    Jeffrey L Anderson;John F Carlquist;John F Carlquist;Joseph B Muhlestein;Joseph B Muhlestein;Benjamin D Horne;Benjamin D Horne

  • Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease and Serological Evidence for Chlamydia pneumoniae Infection The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) Study

    Jeffrey L. Anderson;Joseph B. Muhlestein;John Carlquist;Ann Allen

  • Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.

    Christopher M. O'Connor;Michael W. Dunne;Marc A. Pfeffer;Joseph B. Muhlestein

  • Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia.

    T. Jared Bunch;J. Peter Weiss;Brian G. Crandall;Heidi T. May

  • Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.

    Joseph B. Muhlestein;Joseph B. Muhlestein;Donald L. Lappé;Donald L. Lappé;Joao A. C. Lima;Boaz D. Rosen

  • Prospective Study of Pathogen Burden and Risk of Myocardial Infarction or Death

    J Zhu;F J Nieto;B D Horne;J L Anderson

  • Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery Disease

    Jeffrey L. Anderson;Joseph B. Muhlestein;Benjamin D. Horne;John F. Carlquist

  • Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial.

    Matthew J Budoff;Deepak L Bhatt;April Kinninger;Suvasini Lakshmanan

  • Large-Scale Gene-Centric Analysis Identifies Novel Variants for Coronary Artery Disease

    Adam S. Butterworth;Peter S. Braund;Martin Farrall;Robert J. Hardwick

  • C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina.

    James S Zebrack;Joseph B Muhlestein;Benjamin D Horne;Jeffrey L Anderson

  • Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease Primary Clinical Results of the ACADEMIC Study

    Joseph B. Muhlestein;Jeffrey L. Anderson;John F. Carlquist;Kirti Salunkhe

Frequent Co-Authors

Benjamin D. Horne
Benjamin D. Horne Stanford University
Jeffrey L. Anderson
Jeffrey L. Anderson University of Utah
Dale G. Renlund
Dale G. Renlund University of Utah
Nicola J. Camp
Nicola J. Camp University of Utah
Roxana Mehran
Roxana Mehran Icahn School of Medicine at Mount Sinai
Timothy D. Henry
Timothy D. Henry Cedars-Sinai Medical Center
Samir R. Kapadia
Samir R. Kapadia Cleveland Clinic
Sunil V. Rao
Sunil V. Rao Duke University School of Medicine
William S. Weintraub
William S. Weintraub Georgetown University
J. Wouter Jukema
J. Wouter Jukema Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the USA isn’t limited to traditional medical school. There are many online degrees and career pathways in healthcare, especially for those interested in nursing and advanced practice roles. Flexibility, cost, and entry requirements vary—so it’s important to find the option that fits your life and career goals.

For those with a Bachelor of Science in Nursing and looking to reach leadership positions, cheapest dnp programs offer a pathway to the highest level of clinical expertise without heavy financial burden. If you’re a registered nurse wanting to advance your credentials, there are affordable rn to bsn programs available online, designed to complement your work schedule.

Individuals without a nursing background can pursue healthcare by enrolling in online msn programs for non nurses, helping them transition quickly into nursing roles. For aspiring nurses concerned about the competitive nature of admissions, some direct entry nursing programs are more accessible, allowing students to start their journey in medicine sooner.

Best Scientists Citing Joseph B. Muhlestein

Trending Scientists